Adage Capital Partners’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-320,000
| Closed | -$5.82M | – | 954 |
|
|
2024
Q3 | $5.82M | Sell |
320,000
-280,000
| -47% | -$5.09M | 0.01% | 698 |
|
|
2024
Q2 | $11.4M | Hold |
600,000
| – | – | 0.02% | 573 |
|
|
2024
Q1 | $13M | Buy |
+600,000
| New | +$13M | 0.02% | 551 |
|
|
2023
Q1 | – | Sell |
-700,000
| Closed | -$10.7M | – | 984 |
|
|
2022
Q4 | $10.7M | Hold |
700,000
| – | – | 0.03% | 615 |
|
|
2022
Q3 | $7.03M | Buy |
700,000
+135,000
| +24% | +$1.35M | 0.02% | 727 |
|
|
2022
Q2 | $6.7M | Buy |
565,000
+15,000
| +3% | +$178K | 0.02% | 765 |
|
|
2022
Q1 | $10.5M | Hold |
550,000
| – | – | 0.02% | 681 |
|
|
2021
Q4 | $13.1M | Buy |
550,000
+105,556
| +24% | +$2.52M | 0.02% | 616 |
|
|
2021
Q3 | $9.16M | Hold |
444,444
| – | – | 0.02% | 714 |
|
|
2021
Q2 | $11.6M | Hold |
444,444
| – | – | 0.02% | 651 |
|
|
2021
Q1 | $10.2M | Buy |
+444,444
| New | +$10.2M | 0.02% | 666 |
|